MedTrace Logo

Daily Low Oxygen Exposure and Weight Status

NCT04801810 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2022-04-01

No results posted yet for this study

Summary

The objective of this single-blind, parallel-arm, randomized clinical trial is to evaluate changes in body weight and composition, assess determinants of energy balance, and measure modulators of energy intake and expenditure, following 8 wk of calorie restriction (CR, -500 kcal/d) in combination with either overnight exposure (8 h/night) to normobaric hypoxia (NH; 15% oxygen, \~8500 ft elevation) or normoxia (NN; 21% oxygen, sea level), using a commercially available, in-home tent system, in adults who are overweight or obese.

Conditions

  • Overweight and Obesity

Interventions

OTHER

Normobaric hypoxia

Low oxygen exposure to mimic \~8500 feet elevation (experimental).

OTHER

Normobaric normoxia

Normal oxygen exposure to mimic sea level conditions (sham comparator).

Sponsors & Collaborators

  • Florida State University

    lead OTHER

Principal Investigators

  • Claire E Berryman, PhD · Florida State University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-05-31
Primary Completion
2023-05-31
Completion
2023-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04801810 on ClinicalTrials.gov